Application of Amniotic Membrane Allografts in Advanced Venous Leg Ulcer: A Case Study and Literature Review

Matthew Regulski; John Shou; Naomi Lambert*; Eric Vinke; Tyler Barrett

**Matthew Regulski, John Shou, Naomi Lambert*, Eric Vinke and Tyler Barrett**

Volume3-Issue9
Dates: Received: 2022-09-01 | Accepted: 2022-09-06 | Published: 2022-09-07
Pages: 1007-1011

Abstract

Chronic Venous Insufficiency (CVI) is a lifelong, moribund and debilitating disease process with tremendous personal and financial costs. At its core, CVI involves blood pooling in the lower extremities secondary to inadequate venous blood return, resulting in venous hypertension and incompetence of the one-way valves in the lower extremity veins. As venous circulation slows, metabolic demands of the cells in the lower extremities increase, leading to stasis dermatitis, infection, cellular death, and venous ulceration. This case study aims to report the efficacy of Dehydrated Amniotic Membrane Allograft (DAMA) applications to a chronic right lateral ankle ulcer resulting from chronic venous insufficiency.

The patient in this study received DAMA applications weekly for six weeks. Upon examination at the initial application, the wound was wet and macerated due to drainage with significant hemosiderosis and lipodermatosclerosis consistent with a Venous Clinical Severity Score (VCSS) of 2. Upon inspection at the final visit, the wound was closed, with a VCSS of 0. This case study demonstrates that the application of DAMA has the potential to act as an effective barrier to cover and accelerate wound closure time. Future non randomized and randomized controlled trials may further establish standardized protocols for DAMA application in venous ulceration, help create treatment algorithms to predict wound closure endpoints, and encourage innovation that may further accelerate healing time.

FullText HTML FullText PDF DOI: 10.37871/jbres1545

Certificate of Publication

Copyright

How to cite this article

Regulski M, Shou J, Lambert N, Vinke E, Barrett T. Application of Amniotic Membrane Allografts in Advanced Venous Leg Ulcer: A Case Study and Literature Review. J Biomed Res Environ Sci. 2022 Sep 07; 3(9): 1007-1011. doi: 10.37871/jbres1545, Article ID: JBRES1545, Available at: https://www.jelsciences.com/articles/jbres1545.pdf

Subject area(s)

Vascular Medicine

References

Kim Y, Png CYM, Sumpio BJ, DeCarlo CS, Dua A. Defining the human and health care costs of chronic venous insufficiency. Semin Vasc Surg. 2021 Mar;34(1):59-64. doi: 10.1053/j.semvascsurg.2021.02.007. Epub 2021 Feb 3. PMID: 33757637.
O'Banion LAA, Siada S, Cutler B, Kochubey M, Collins T, Ali A, Tenet M, Dirks R, Kiguchi MM. Thrombotic complications after radiofrequency and cyanoacrylate endovenous ablation: Outcomes of a multicenter real-world experience. J Vasc Surg Venous Lymphat Disord. 2022 Jul 16:S2213-333X(22)00272-4. doi: 10.1016/j.jvsv.2022.05.009. Epub ahead of print. PMID: 35843596.
Agale SV. Chronic leg ulcers: Epidemiology, aetiopathogenesis, and management. Ulcers. 2013;9. doi: 10.1155/2013/413604.
Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130(4):333-346. doi: 10.1161/CIRCULATIONAHA.113.006898.
Chung KC, Saddawi-Konefka D, Haase SC, Kaul G. A cost-utility analysis of amputation versus salvage for Gustilo type IIIB and IIIC open tibial fractures. Plast Reconstr Surg. 2009 Dec;124(6):1965-1973. doi: 10.1097/PRS.0b013e3181bcf156. PMID: 19952652; PMCID: PMC2788746.
Berti-Hearn L, Elliott B. Chronic venous insufficiency: A review for nurses. Nursing. 2019 Dec;49(12):24-30. doi: 10.1097/01.NURSE.0000604688.03299.aa. PMID: 31658230.
Vasquez MA, Rabe E, McLafferty RB, Shortell CK, Marston WA, Gillespie D, Meissner MH, Rutherford RB; American Venous Forum Ad Hoc Outcomes Working Group. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg. 2010 Nov;52(5):1387-96. doi: 10.1016/j.jvs.2010.06.161. Epub 2010 Sep 27. PMID: 20875713.
McNichol L, Ratliff C, Yates S. Wound, ostomy and continence nurses society core curriculum: Wound management. Lippincott Williams & Wilkins; 2021.
ElHeneidy H, Omran E, Halwagy A, Al-Inany H, Al-Ansary M, Gad A. Amniotic membrane can be a valid source for wound healing. Int J Womens Health. 2016 Jun 27;8:225-31. doi: 10.2147/IJWH.S96636. PMID: 27390533; PMCID: PMC4930235.
Ortega MA, Fraile-Martínez O, García-Montero C, Álvarez-Mon MA, Chaowen C, Ruiz-Grande F, Pekarek L, Monserrat J, Asúnsolo A, García-Honduvilla N, Álvarez-Mon M, Bujan J. Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management. J Clin Med. 2021 Jul 22;10(15):3239. doi: 10.3390/jcm10153239. PMID: 34362022; PMCID: PMC8348673.
Shai A, Halevy S. Direct triggers for ulceration in patients with venous insufficiency. Int J Dermatol. 2005 Dec;44(12):1006-9. doi: 10.1111/j.1365-4632.2005.02317.x. PMID: 16409265.
Frykberg RG, Banks J. Challenges in the Treatment of Chronic Wounds. Adv Wound Care (New Rochelle). 2015 Sep 1;4(9):560-582. doi: 10.1089/wound.2015.0635. PMID: 26339534; PMCID: PMC4528992.
Herber OR, Schnepp W, Rieger MA. A systematic review on the impact of leg ulceration on patients' quality of life. Health Qual Life Outcomes. 2007 Jul 25;5:44. doi: 10.1186/1477-7525-5-44. PMID: 17651490; PMCID: PMC1947954.
Moore MC, Van De Walle A, Chang J, Juran C, McFetridge PS. Human Perinatal-Derived Biomaterials. Adv Healthc Mater. 2017 Sep;6(18):10.1002/adhm.201700345. doi: 10.1002/adhm.201700345. Epub 2017 Aug 7. PMID: 28783879; PMCID: PMC5733692.
Mamede AC, Carvalho MJ, Abrantes AM, Laranjo M, Maia CJ, Botelho MF. Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res. 2012 Aug;349(2):447-58. doi: 10.1007/s00441-012-1424-6. Epub 2012 May 18. PMID: 22592624.
Barr SM. Dehydrated Amniotic Membrane Allograft for Treatment of Chronic Leg Ulcers in Patients With Multiple Comorbidities: A Case Series. J Am Coll Clin Wound Spec. 2016 Feb 4;6(3):38-45. doi: 10.1016/j.jccw.2016.01.002. PMID: 27104144; PMCID: PMC4828514.
Huether SE, McCance KL. Understanding pathophysiology. 2020.
Bianchi C, Cazzell S, Vayser D, Reyzelman AM, Dosluoglu H, Tovmassian G; EpiFix VLU Study Group. A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix® ) allograft for the treatment of venous leg ulcers. Int Wound J. 2018 Feb;15(1):114-122. doi: 10.1111/iwj.12843. Epub 2017 Oct 11. PMID: 29024419; PMCID: PMC7949978.
Francis J, Shajimon CR, Bhat AK, Kanakambaran B. Use of Amnion Transfer in Resistant Nonhealing Venous Leg Ulcers. Indian J Surg. 2015 Dec;77(Suppl 2):457-62. doi: 10.1007/s12262-013-0875-7. Epub 2013 Jan 31. PMID: 26730045; PMCID: PMC4692879.
Ma H, O'Donnell TF Jr, Rosen NA, Iafrati MD. The real cost of treating venous ulcers in a contemporary vascular practice. J Vasc Surg Venous Lymphat Disord. 2014 Oct;2(4):355-61. doi: 10.1016/j.jvsv.2014.04.006. Epub 2014 Jun 24. PMID: 26993537.
Becker C, Regulski M, Martin S, Barrett T. Application of dehydrated amniotic membrane allografts in advanced diabetic foot ulceration: Case Report and Review of Literature. Reports. 2022;5(3):28. doi: 10.3390/reports5030028.s.
Place of service code set. CMS. (n.d.). 2022.